All In Biotech

Drug Trial Radar · NCT01657019

Open Label Extension in Adults With Binge Eating Disorder (BED)

A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder

Last checked: Nov 19, 2026Latest source record: Jun 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

604

Actual

Start

Aug 21, 2012

Primary completion

Oct 21, 2014

Study completion Oct 21, 2014

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Aug 3, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and tolerability of SPD489 administered as a daily morning dose (50 or 70mg) in the treatment of moderate to severe binge eating disorder (BED) in adults

Conditions

  • Binge Eating Disorder

Interventions

  • Lisdexamfetamine dimesylateDrug

    50 or 70 mg administered orally, once a day for 52 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) as a Measure of SafetyTime frame: 52 weeks
  2. Number of Participants With a Positive Response on The Columbia Suicide Severity Rating Scale (C-SSRS)Time frame: 53 weeks

Locations

89 sites in 3 countries. Site status is shown where the registry gives one.

  • Birmingham Research Group

    Birmingham, Alabama

  • Radiant Research

    Tucson, Arizona

  • Clinical Study Centers, LLC

    Little Rock, Arkansas

  • Southwestern Research, Inc.

    Beverly Hills, California

  • TRIMED Clinical Trials

    Corona, California

  • Pharmacology Research Institute

    Encino, California

  • Scripps Clinical Research Services

    La Jolla, California

  • Pharmacology Research Institute

    Los Alamitos, California

  • Pharmacology Research Institute

    Newport Beach, California

  • Pacific Research Partners, LLC

    Oakland, California

  • Excell Research, Inc

    Oceanside, California

  • PCSD - Feighner Research

    San Diego, California

  • Western Affiliated Research Institute, Inc

    Denver, Colorado

  • Radiant Research, Inc

    Denver, Colorado

  • Florida Clinical Research

    Bradenton, Florida

  • Gulfcoast Clinical Research

    Fort Myers, Florida

  • Clinical Neuroscience Solutions, Inc

    Jacksonville, Florida

  • Fidelity Clinical Research, Inc

    Lauderhill, Florida

  • Compass Research, LLC

    Leesburg, Florida

  • Florida Clinical Research Center, LLC

    Maitland, Florida

  • Scientific Clinical Research, Inc

    North Miami, Florida

  • Clinical Neuroscience Solutions, Inc

    Orlando, Florida

  • Miami Research Associates

    South Miami, Florida

  • Atlanta Institute of Medicine and Research

    Atlanta, Georgia

  • Neurotrials Research, Inc

    Atlanta, Georgia

  • Capstone Clinical Research

    Libertyville, Illinois

  • Baber Research Group

    Naperville, Illinois

  • American Medical Research, Inc

    Oak Brook, Illinois

  • Goldpoint Clinical Research, LLC

    Indianapolis, Indiana

  • Deaconess Health Center

    Newburgh, Indiana

  • Clinical Trials Technology, Inc

    Prairie Village, Kansas

  • Cypress Medical Research Center, LLC

    Wichita, Kansas

  • Louisana Research Associates, Inc

    New Orleans, Louisiana

  • McLean Hospital

    Belmont, Massachusetts

  • Boston Clinical Trials

    Boston, Massachusetts

  • Activmed Practices & Research

    Methuen, Massachusetts

  • Adams Clinical Trials, LLC

    Watertown, Massachusetts

  • Rochester Center for Behavioral Medicine

    Rochester Hills, Michigan

  • University of Minnesota

    Minneapolis, Minnesota

  • St. Charles Psychiatric Associates-Midwest Research Group

    Saint Charles, Missouri

Showing 40 of 89 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.